Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-170691
Filing Date
2009-08-10
Accepted
2009-08-10 16:25:41
Documents
9
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 890892
2 ARCA BIOPHARMA, INC. EMPLOYEE SEVERANCE BENEFIT PLAN dex103.htm EX-10.3 75117
3 ARCA BIOPHARMA, INC. 2009 REDUCTION IN FORCE SEVERANCE BENEFIT PLAN dex104.htm EX-10.4 68391
4 FORM OF OPTION AMENDMENT dex105.htm EX-10.5 3858
5 FORM OF OPTION AGREEMENT AND GRANT NOTICE dex106.htm EX-10.6 77925
6 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 5826
7 CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 5677
8 CERTIFICATION OF THE CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 5479
9 GRAPHIC g89145ex10-6pg11.jpg GRAPHIC 411
  Complete submission text file 0001193125-09-170691.txt   1135500
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 091000224
SIC: 2835 In Vitro & In Vivo Diagnostic Substances